EMCDDA Home
  • EN
Search

EMCDDA–Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole

EMCDDA, Lisbon, February 2013

Publication type:

Joint Reports

Summary:

At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.

Download as pdf (454Kb):

English (en)

Table of contents

  • Introduction
  • Information collection process
  • Information required by Article 5.2 of the Decision
  • Information from the EMA as requested by Article 5.3 of the Decision
  • Summary of findings
  • Conclusions

Annexes

  • Annex 1 — Main information sources
  • Annex 2 — Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
  • Annex 3 — Deaths associated with 5-(2-aminopropyl)indole (5-IT) reported
    to the EMCDDA

Pages:

38

Price:

free

ISBN/ISSN:

978-92-9168-596-7

Catalogue number:

TDAS13001ENN

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Thursday, 30 January 2014